PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three months ended March 31, 2016.
Financial highlights of the first quarter of 2016 include (all comparisons are with the first quarter of 2015 unless otherwise noted):
Financial highlights of the first quarter of 2016 include (all comparisons are with the first quarter of 2015 unless otherwise noted):
